These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1688263)

  • 21. Antioxidant activity and other mechanisms of thiols involved in chemoprevention of mutation and cancer.
    De Flora S; Izzotti A; D'Agostini F; Cesarone CF
    Am J Med; 1991 Sep; 91(3C):122S-130S. PubMed ID: 1928203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNAs as targets for dietary and pharmacological inhibitors of mutagenesis and carcinogenesis.
    Izzotti A; Cartiglia C; Steele VE; De Flora S
    Mutat Res; 2012; 751(2):287-303. PubMed ID: 22683846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimutagenesis and anticarcinogenesis, from the past to the future.
    Weisburger JH
    Mutat Res; 2001 Sep; 480-481():23-35. PubMed ID: 11506796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antievolutionary component of antimutagenesis and anticarcinogenesis: where do mutation rates come from and where are they going?
    Drake JW
    Mutat Res; 1996 Feb; 350(1):5-8. PubMed ID: 8657196
    [No Abstract]   [Full Text] [Related]  

  • 25. Janus carcinogens and mutagens.
    von Borstel RC; Higgins JA
    Mutat Res; 1998 Jun; 402(1-2):321-9. PubMed ID: 9675327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A correlative approach for the identification of antimutagens that demonstrate chemopreventive activity.
    Shamon LA; Chen C; Mehta RG; Steele V; Moon RC; Pezzuto JM
    Anticancer Res; 1994; 14(5A):1775-8. PubMed ID: 7847810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synopsis of the first International Conference on Antimutagenesis and Anticarcinogenesis: mechanisms.
    Shankel DM; Hartman PE; Kada T; Hollaender A
    Environ Mutagen; 1987; 9(1):87-103. PubMed ID: 3100291
    [No Abstract]   [Full Text] [Related]  

  • 28. [Mutagenesis, antimutagenesis, DNA repair].
    Zasukhina GD; Sinel'shchikova TA
    Vestn Ross Akad Med Nauk; 1993; (1):9-14. PubMed ID: 7682126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanistic considerations in the evaluation of chemopreventive data.
    Kelloff GJ; Boone CW; Steele VE; Crowell JA; Lubet RA; Greenwald P; Hawk ET; Fay JR; Sigman CC
    IARC Sci Publ; 1996; (139):203-19. PubMed ID: 8923032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antimutagenesis as a genetic process].
    Goncharova RI
    Vestn Ross Akad Med Nauk; 1993; (1):26-33. PubMed ID: 7682119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New approaches to antimutagenesis.
    Heddle JA; Moody J; Thompson LU; Torous DK; Trentin G
    J Environ Pathol Toxicol Oncol; 1999; 18(2):95-101. PubMed ID: 15281220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dietary interventions of human carcinogenesis.
    DeMarini DM
    Mutat Res; 1998 May; 400(1-2):457-65. PubMed ID: 9685704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antimutagens and anticarcinogenic agents, identification and mechanisms of action of food xenobiotics].
    el Hamss R; Idaomar M
    Therapie; 2002; 57(6):512-7. PubMed ID: 12666257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimutagenesis and anticarcinogenesis mechanisms. Proceedings of the International Conference on Mechanisms of Antimutagenesis and Anticarcinogenesis. October 6-10, 1985, Lawrence, Kansas. Dedicated to Dr. Charlotte Auerbach and Dr. Takashi Sugimura.
    Basic Life Sci; 1986; 39():1-605. PubMed ID: 3533038
    [No Abstract]   [Full Text] [Related]  

  • 35. Overview of mechanisms of cancer chemopreventive agents.
    De Flora S; Ferguson LR
    Mutat Res; 2005 Dec; 591(1-2):8-15. PubMed ID: 16107270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
    Greenwald P
    J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antimutagenesis as organism defense system against damaging factors of endogenous and exogenous origin].
    Dvornyk AS; Pererva TP; Kunakh VA
    Tsitol Genet; 2004; 38(5):62-71. PubMed ID: 15771091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perspectives in cancer chemoprevention.
    Stoner GD; Morse MA; Kelloff GJ
    Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):945-54. PubMed ID: 9255586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic and epigenetic cancer chemoprevention on molecular targets during multistage carcinogenesis.
    Kim HS; Kacew S; Lee BM
    Arch Toxicol; 2016 Oct; 90(10):2389-404. PubMed ID: 27538406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Tularemia live vaccine as a modifier of tumorigenesis and carcinogenesis].
    Nersesian AK; Galstian AM; Adamian RT
    Vopr Onkol; 2004; 50(1):28-35. PubMed ID: 15088516
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.